Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aceragen Inc ACGN

Healthcare Biotechnology
Aceragen, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and... see more

Recent & Breaking News (NDAQ:ACGN)

Idera Pharmaceuticals Presents Pre-Clinical Data from IMO-2125 Treatment in Combination with Ipilimumab that Demonstrates Induction of Durable Anti-tumor Responses Associated with Tumor-Specific Memory

GlobeNewswire September 8, 2017

Idera to Host Investor Conference Call on Monday, September 11, 2017 at 9:00 A.M. E.T.

GlobeNewswire September 6, 2017

Idera to Present at the 2017 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 11, 2017

Idera Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire August 7, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  July 18, 2017

Technical Insights on Biotech Stocks -- Idera Pharma, Pieris Pharma, Peregrine Pharma, and Ritter Pharma

PR Newswire July 5, 2017

Idera Announces FDA Orphan Drug Designation for IMO-2125 for the Treatment of Melanoma

GlobeNewswire June 22, 2017

Idera to Present at the Jefferies 2017 Healthcare Conference

GlobeNewswire June 5, 2017

How These Biotech Stocks are Faring? -- Idera Pharma, BioTime, RXi Pharma, and Tenax Therapeutics

PR Newswire May 24, 2017

Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire May 4, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  April 25, 2017

Idera Pharmaceuticals Advances Investigational Treatment – Intratumoral IMO-2125 in Combination with Ipilimumab - for Unmet Need in Anti-PD-1 Refractory Metastatic Melanoma

GlobeNewswire April 11, 2017

Mid-Morning Market Update: Markets Open Higher; Walgreens Sales Miss Views

Benzinga.com  April 5, 2017

Idera Pharmaceuticals Presents Clinical Translational and Pre-Clinical Data from IMO-2125 Development Program at the American Association for Cancer Research (AACR) 2017 Annual Meeting

GlobeNewswire April 5, 2017

Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment

PR Newswire Europe Non Regulatory March 28, 2017

Mid-Afternoon Market Update: Sears Drops After Warning Of Ability To Continue As A Going Concern; Idera Pharma Shares Surge

Benzinga.com  March 22, 2017

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  March 22, 2017

Mid-Day Market Update: Duluth Surges On Earnings Beat; Diana Containerships Shares Plummet

Benzinga.com  March 22, 2017

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update

GlobeNewswire March 15, 2017

Idera to Present at the 37th Annual Cowen and Company Health Care Conference

GlobeNewswire March 2, 2017